The HIV-1 Tat protein interaction with its RNA recognition sequence TAR is
an important drug target and model system for the development of specific R
NA-protein inhibitors. 2'-O-methyl oligoribonucleotides complementary to th
e TAR apical stem-loop effectively block Tat binding in vitro. Substitution
by 5-propynylC or 5-methylC LNA monomeric units into a 12-mer 2'-O-methyl
oligoribonucleotide leads to stronger inhibition, as does a 12-mer PNA. 10-
16 mer 2'-O-methyl oligoribonucleotides give sequence- and dose-dependent i
nhibition of Tat-dependent transcription of an HIV DNA template in HeLa cel
l nuclear extract. Inhibition is maintained for the substituted 12-mer anal
ogues but is poorer for PNA and is not correlated with TAR binding strength
.